Healthcare Industry Perspective - The healthcare industry should prioritize listening to and believing patients, even when objective evidence is lacking [2][8] - The industry needs to integrate intuition and patient narratives into evaluations, alongside evidence-based medicine [3] - The industry should expand its approach to include nuances, root cause investigations, and early intervention [4] - A validating statement can be as powerful as a prescription [2] - Curiosity is a clinical skill, and efficiency should not come at the expense of overlooking patients [2] Patient Care & Diagnosis - Healing involves understanding the patient's life holistically, including social, emotional, and nutritional aspects [1] - The absence of evidence is not the absence of truth; the body communicates in ways beyond numbers [2] - Healthcare providers should focus on what the body is trying to say, not just diagnosis and medication [1] - Trusting patients and their instincts is crucial for healing [4] - Patients should advocate for themselves if they feel something is wrong [7]

[Music] [Applause] When my patients say they don't feel well, I believe them. But I didn't always see it that way. I was trained as a medical doctor to follow the evidence to diagnose based on what could be measured, quantified, and explained. And for a long time, I believed that if the labs were normal, the patient was fine. Until one day, I wasn't fine. And nothing could explain it. Just three months after giving birth to my first child, I sat in a doctor's office. I was exhausted, foggy, aching. I was af ...

Financial Performance - Revenue for Q2 2025 reached $10.2 million, a 42% increase compared to $7.2 million in Q2 2024 [13] - Gross profit for Q2 2025 was $8.0 million, up 52% from $5.2 million in Q2 2024 [13] - Gross margin improved to 78.3% in Q2 2025, a 513 basis point increase from 73.2% in Q2 2024 [13] - Operating income for Q2 2025 was $1.9 million, a 6% decrease compared to $2.0 million in Q2 2024 [13] - Adjusted EBITDA for the three months ended June 30, 2025, was $3.37 million, compared to $1.457 million for the same period in 2024 [18] UltraMIST Performance - UltraMIST saw continuous revenue growth in 2024 and strong year-over-year growth in Q2 2025 [20] - The company had 1,261 UltraMIST systems in the field at the end of Q2 2025 [22] - 116 UltraMIST systems were sold in Q2 2025, compared to 72 in Q2 2024 and 98 in Q1 2025 [22] Revenue Guidance - The company projects Q3 2025 revenue to be between $12 million and $12.7 million, compared to $9.36 million in Q3 2024 [25] - The company targets full-year 2025 revenue to be between $48 million and $50 million, representing a 47-53% increase compared to $32.6 million in FY 2024 [25]